Tabnak P, Ghasemi Y, Natami M, Khorram R, Ebrahimnezhad M. Role of m(6)A modification in dysregulation of Wnt/β-catenin pathway in cancer. Biomed Pharmacother 2023;157:114023. [PMID: 36403567 DOI: 10.1016/j.biopha.2022.114023][Reference Citation Analysis]
2
Gulati R, Hanlon MA, Lutz M, Quitmeyer T, Geller J, Tiao G, Timchenko L, Timchenko N. Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma. Cancers (Basel) 2022;14. [PMID: 36551548 DOI: 10.3390/cancers14246062][Reference Citation Analysis]
3
Leung RWH, Lee TKW. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers 2022;14:5468. [DOI: 10.3390/cancers14215468][Reference Citation Analysis]
4
Papoutsoglou P, Louis C, Pineau R, L’haridon A, Banales JM, Gilot D, Aubry M, Coulouarn C. TGFβ-induced long non-coding RNA LINC00313 activates Wnt signalling and promotes cholangiocarcinoma progression.. [DOI: 10.21203/rs.3.rs-1967984/v1][Reference Citation Analysis]